Description
Objectives
1. Define Treatment-Resistant Depression (TRD)
2. Recognize risk factors of Treatment-Resistant Depression
3. Understand and prioritize biological and psychosocial methods in management of Treatment-Resistant Depression
4. Understand the logic behind the framework of how to manage Treatment-Resistant Depression
5. Become familiar with new and developing treatments of Treatment-Resistant Depression
Description:
We generally know Treatment-Resistant Depression to be a subset (thought to be as high as 30%) of Major Depressive Disorder. Treatment-resistant depression or TRD, is when depression does not respond respond to traditional and first-line therapeutic treatments. Patients can suffer greatly for years without relief. In this webinar, we’ll define TRD; explore the risk factors of TRD; learn how to prioritize biological and psycho-social methods in the management of TRD; explain the logic behind the framework of how to manage TRD and discuss some new and developing treatments for treatment-resistant depression. We invite you to join us, along with our speaker, and leading researcher and expert on TRD, practising psychiatrist Dr. Iouri Ryback, from London, Ontario
Who Should Attend?:
• Nurses, Physicians, Psychologists, Mental Health Nurses, Therapists in all settings
• Primary Care Nurses and Physicians; MH Staff in Community Settings
• Social Workers & Allied Professional Staff in Mental Health and Addictions Settings settings
• Intake & Front Line Staff; Mental Health Managers and Educators
• Mental Health Nurses and Staff in Adolescent and Adult Correctional & Forensic Settings
Iouri Rybak MD, FRCPC
Dr. Rybak is an Associate Professor, the Department of Psychiatry, Western University, in London, Ontario. He currently practises at the Parkwood Institute and is a researcher at the Lawson Health Research Institute. Dr. Rybak is one of Canada’s leading medical researchers on Treatment Resistant Depression and a significant part of his clinical, educational and research activities are related to Treatment Resistant Depression (TRD) and neuromodulation. He has also contributed to the field of Chronobiology of ADHD and Depression.
